Send to

Choose Destination
Clin J Pain. 2008 Feb;24(2):93-7. doi: 10.1097/AJP.0b013e31815ca2b4.

Buprenorphine: new tricks with an old molecule for pain management.

Author information

Department of Medicine, Georgetown School of Medicine, Fairfax, VA 22031, USA.

Erratum in

  • Clin J Pain. 2008 May;24(4):370.


Sublingual buphrenorphine is a unique opioid medication based on its pharmacokinetics and pharmacodynamic properties. It may be used "on label" as an alternative choice to methadone for the treatment of opioid addiction or "off-label" for the treatment of both acute and chronic pain. Because of high mu receptor affinity and resultant blockade, it has been suggested that this might interfere with the management of moderate to severe pain in patients on opioid agonist treatment. The following article will offer strategies and approaches to address some of these real and perceived challenges.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center